Kenya launches cloud-based portal to improve vaccine delivery
NAIROBI, May 14 (Xinhua) -- Kenya's Ministry of Health launched a cloud-based portal on Wednesday to ensure that vaccines are delivered across the country seamlessly.
Aden Duale, cabinet secretary in the ministry, said the Kenya Electronic National Vaccine and Immunization Portal will build a comprehensive and real-time repository for vaccine and immunization data management.
"This is an innovative digital platform that will enhance decision-making and increase visibility, traceability, accountability, and effectiveness in vaccine service delivery countrywide," Duale said during the inauguration of the portal in Nairobi, the Kenyan capital.
According to Duale, the portal is aimed at strengthening Kenya's immunization infrastructure while protecting the health of children and other vulnerable demographics.
He added that a concrete plan is in place to facilitate the transition of the data repository to the government's data center.
Meanwhile, Duale flagged off the distribution of 2,000 cold chain equipment to boost primary healthcare in the country.
He said the cold chain equipment, which are refrigerators, is powered by solar and electricity along with accessories like cold boxes and temperature monitors, adding that the government has invested 16 million U.S. dollars to boost disease surveillance and prevention.
Duale said the country is now equipped to reach every child with life-saving vaccines, regardless of their geographical location, economic status, or infrastructural challenges.
He stressed that investing in a robust immunization program is key to dealing with emerging health challenges while inching closer to the realization of universal health coverage in Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
7 hours ago
- The Star
Feature: How an Ethiopian entrepreneur turns fungus into fortune?
by Xinhua writers Habtamu Worku, Liu Fangqiang ADDIS ABABA, June 3 (Xinhua) -- In the highlands of Ethiopia, a local entrepreneur's fascination with mushrooms has sparked a surprising culinary movement, reshaping local diets and creating new economic opportunities. Mikias Tadesse, 29, recalled how his mushroom curiosity turned his life around, from a truck driver to a successful mushroom farmer, ultimately promoting a culinary change in Ethiopia. Tadesse's curiosity began about three years ago upon his first encounter with a fleshy cluster of sprouted mushrooms in the backyard of a Chinese road construction camp in a remote village in southern Ethiopia. "Intrigued by a sight foreign to my Ethiopian culinary experience and out of curiosity, I decided to try a mushroom dish prepared by the Chinese chefs. To my surprise, I really enjoyed the dish," said Tadesse. Tadesse also found the vast potential of mushrooms to diversify Ethiopia's culinary landscape and bolster food security, thanks to their ease of cultivation and quick harvest cycle. He then discussed the idea of starting mushroom cultivation with his Chinese colleagues. "Their response was immediate and very encouraging. They fully supported my business idea and promised to assist me in this new venture." "From the very beginning, the Chinese agricultural experts have been the lifeline of my mushroom farm. They provided me with extensive technical knowledge through hands-on training and material support, including quality spawns that are necessary to navigate the delicate process of fungal cultivation," he said. Tadesse's biggest challenge, however, was the public's unfamiliarity with mushrooms in Ethiopia. "I faced major market resistance because most people simply did not see mushrooms as food," he said. "Even though I knew some restaurants and hotels in Addis Ababa served dishes with mushrooms, I had to visit nearly every supermarket and hotel to promote my products. Initially, I received countless rejections and skepticism," he recalled. After many attempts, his persistence finally paid off. Despite the minimal demand from their customers, some supermarkets agreed to stock his mushrooms. During the first six months, Tadesse often retrieved nearly half of the mushrooms from their shelves after three or four days. Gradually, he started to notice the growing demand for mushrooms as the orders from his partner supermarkets increased. Buoyed by growing demand, he expanded his farm to four mushroom cultivation sheds, each spanning 250 square meters. Today, the young entrepreneur cultivates vibrant Yellow mushrooms, King Trumpets, and Oyster mushrooms. "Though our farm produces an average of 50 kg of different varieties of mushrooms and has 12 dedicated workers, we are struggling to meet the growing demand," Tadesse said. Although he has found success in mushroom cultivation, he remains deeply grateful to the Chinese experts. "Their support forms the foundation of our farm and business. From securing premium Chinese spawns to providing cutting-edge technical knowledge and tools, their assistance has been transformative." Zheng Aibao, 59, who specializes in mushroom cultivation, is among the eight Chinese agricultural experts working in Ethiopia. "This is my third time in Ethiopia. I am glad to see the mushroom cultivation method introduced by Chinese experts is taking root in five farms in the country," said Zheng. As for Tadesse, his long-term goal is to deepen his knowledge of mushroom cultivation and start exporting processed mushrooms. "I believe that with coordinated efforts from both government and private sectors, mushrooms will end up on more dinner tables across Ethiopia and really help add variety to what people eat," Tadesse said.
Malaysian Reserve
21 hours ago
- Malaysian Reserve
Elon Musk's Neuralink closes Series E funding round
SAN FRANCISCO — Elon Musk's (picture) brain computer interface startup Neuralink announced on Monday that it has closed a US$650 million funding round, Xinhua reported. The Series E fundraiser included investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others, the company said in a blog post. Neuralink last raised a US$280 million Series D funding round in 2023, with an additional US$43 million tranche added months later. The company said it has now conducted more human clinical trials, implanting its brain chips in five individuals with severe paralysis. In May, Neuralink received a Breakthrough Devices Programme designation from the US Food and Drug Administration (FDA). The Breakthrough Devices Programme is a voluntary programme for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, according to the FDA. The programme is intended to provide patients and healthcare providers with timely access to medical devices by speeding up development, assessment, and review for premarket approval. — BERNAMA-XINHUA
The Star
a day ago
- The Star
Elon Musk's Neuralink closes Series E funding round
SAN FRANCISCO, June 2 (Xinhua) -- Elon Musk's brain computer interface startup Neuralink announced on Monday that the company has closed a 650-million-U.S.-dollar funding round. The Series E fundraise included investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others, the company said in a blog post. Neuralink last raised a 280-million-dollar Series D funding round in 2023, with an additional 43-million-dollar tranche added months later. The company said it has now conducted more human clinical trials, implanting its brain chips in five individuals with severe paralysis. In May, Neuralink received Breakthrough Device Program from the U.S. Food and Drug Administration. The Breakthrough Devices Program is a voluntary program for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, according to the Food and Drug Administration. The program is intended to provide patients and health care providers with timely access to medical devices by speeding up development, assessment, and review for premarket approval.
